Funex

Quick links to important sections

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Funex

What is Funex?

Funex is a pharmaceutical medication classified as a sedative-hypnotic. It is primarily utilized in clinical settings for the short-term management of insomnia, specifically helping individuals who have difficulty falling asleep. The medication works by interacting with specific neurotransmitters in the brain to facilitate a state of relaxation and induce sleep.

Mechanism of Action

The active component in Funex targets the gamma-aminobutyric acid (GABA) receptors in the central nervous system. GABA is an inhibitory neurotransmitter that reduces neuronal excitability. By enhancing the effects of GABA, the medication helps to calm brain activity, which can assist in the transition from wakefulness to sleep.

Clinical Applications

This medication is typically prescribed for patients experiencing transient or short-term sleep disturbances. Its use is generally restricted to brief periods because long-term use can lead to changes in effectiveness. It is designed to address the physiological barriers to sleep onset rather than treating underlying psychological or chronic medical conditions that may be causing the sleep disruption.

Important Considerations

As a central nervous system depressant, Funex affects motor skills and cognitive functions. It is intended for use only when a full night's sleep is possible, as premature awakening may result in lingering grogginess or impaired alertness. Patients are advised to discuss their full medical history with a healthcare provider to ensure the medication is appropriate for their specific situation.

Regulatory References

  1. Fluconazole - StatPearls - NCBI Bookshelf

What side effects are possible with Funex?

Possible Side Effects and Safety Information

The safety profile of Funex, which contains the antifungal agent Fluconazole, is formally documented by regulatory authorities, with adverse effects classified by frequency and affected physiological systems. These classifications distinguish between expected reactions and rare, serious events.

Common adverse reactions, expected to affect up to 1 in 10 individuals, frequently involve the Gastrointestinal Disorders system, manifesting as nausea, vomiting, diarrhoea, and abdominal pain. Effects on the Nervous System Disorders are also common, notably headache, alongside common increases in liver enzymes and rash.

Uncommon effects may include anaemia, dizziness, somnolence, and alopecia (hair loss).

Serious Adverse Reactions and Restrictions

The official labeling documents several serious adverse reactions that are classified as rare. These rare events include severe effects on the Hepatobiliary Disorders system, such as hepatotoxicity and hepatic failure, which can be fatal. Other rare, serious reactions include severe exfoliative cutaneous reactions (like Stevens-Johnson syndrome), anaphylaxis, and Cardiac Disorders such as QT prolongation and Torsade de pointes (TdP).

Safety considerations for specific populations and circumstances are documented. Monitoring is required for patients with renal impairment due to the drug’s elimination pathway and for individuals with existing hepatic disease due to the rare risk of severe liver adverse reactions. Furthermore, the medicine is formally contraindicated for co-administration with specific medications, such as Terfenadine, Astemizole, and Cisapride, because of the potential for the serious Cardiac Disorders mentioned above.

Overdose and Emergency Response

Overdose and When to Seek Help

Overdose with this medication is primarily defined by the serious risk of delayed and potentially fatal liver damage (hepatotoxicity). Regulatory documentation emphasizes that a known or suspected overdose is a medical emergency that requires immediate professional assessment.

Official Overdose Profile

Domain Description (Regulatory Basis)
Primary Risk Acute Liver Failure. Ingestion of a toxic dose can progress to severe liver injury, potentially leading to death or the need for a liver transplant.
Initial Symptoms Initial signs are often non-specific or absent. Early symptoms may include nausea, vomiting, sweating, or general malaise, which do not reliably indicate the severity of the damage.
Time-Sensitivity The specific antidote is most effective when administered quickly, typically within the first 8 hours of an acute ingestion. Delay significantly increases the risk of severe outcomes.
Risk Factors Increased risk of severe hepatotoxicity is officially documented for individuals with pre-existing liver disease, malnutrition, or those taking certain enzyme-inducing medications.

When Immediate Medical Help is Required

Urgent medical attention must be sought immediately following any suspected overdose, even if the individual feels well or has no symptoms. Because initial symptoms are often misleadingly mild, and the efficacy of the life-saving antidote is highly time-dependent, regulatory sources require patients to contact emergency services or a Poison Control Center right away. Do not wait for symptoms to appear before seeking professional help to allow for the rapid initiation of necessary treatment.

Therapeutic Uses of Funex

Funex is a systemic antifungal medicine that is commonly used to help with a wide range of infections caused by fungi or yeast throughout the body, providing supportive relief across several therapeutic domains.

The medication is relevant for easing symptoms associated with conditions such as candidemia, cryptococcal meningitis, oropharyngeal candidiasis (thrush), esophageal candidiasis, and recurrent vaginal candidiasis. Its application is often used in clinical settings that involve acute or unstable symptom patterns, including those in high-risk groups like patients undergoing chemotherapy or transplantation.

Funex supports the management of symptoms related to systemic imbalance, like persistent fever, and is relevant for easing symptoms related to inflammatory or irritative states, such as painful soreness and burning. This supportive relief is applied during difficult episodes and may assist with maintaining functional stability. By addressing these infections, it contributes to improved day-to-day comfort and helps maintain a sense of stability when symptoms are more noticeable.


Quick Fact: Relevant for Systemic and Mucosal Discomfort

Eligibility and Restrictions for Use

Who Can and Cannot Use Funex?

The eligibility for Funex (fluconazole) is strictly defined by regulatory documents, distinguishing between absolute prohibitions and conditional use.

Populations for Whom Use is Contraindicated

Patients must not use Funex if they have a known hypersensitivity to fluconazole or other azole antifungal compounds. It is also contraindicated with the co-administration of specific medications that both prolong the QT interval and are metabolized via the CYP3A4 enzyme (e.g., cisapride, astemizole, quinidine). Specific oral formulations are prohibited in patients with rare hereditary problems like galactose or sucrose intolerance.

Populations Requiring Restricted or Conditional Use

  • Organ Function: Use must be with caution and close monitoring in patients with pre-existing liver dysfunction or impaired renal function (Creatinine clearance le 50 mL/min).
  • Reproductive Status: Pregnant women should generally avoid the medicine, especially high doses (400–800 mg/day) and prolonged regimens, except for life-threatening infections. Breastfeeding is generally not recommended after repeated or high-dose use.
  • Age Groups: The medicine is established for Adults and Adolescents, and for Children six months of age and older for specific indications. However, the safety and efficacy for treating genital candidiasis is not established in the pediatric population.

The resulting eligibility structure establishes mandatory exclusions based on allergy and dangerous drug interactions. Conditional use requires careful assessment for patients with compromised liver, kidney, or heart conditions, or for women who are pregnant or breastfeeding, as formally defined by regulatory authorities.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Funex has documented interactions primarily involving its absorption and systemic exposure, which can be altered by specific medicines and dietary products. The key mechanistic basis for these interactions is the effect on drug transporters, particularly P-glycoprotein (P-gp) and Organic Anion Transporting Polypeptide (OATP).

  • Antacids: Co-administration of Funex with aluminum- or magnesium-containing antacids can reduce the overall absorption of Funex, resulting in lower blood levels. To minimize this effect, a time separation of at least two hours between taking Funex and an antacid product is recommended.

  • Specific Medicines: Inhibitors or inducers of P-gp and OATP transporters may increase or decrease Funex exposure. Medicinal products that inhibit these transporters, such as ketoconazole (an antifungal) or erythromycin (an antibiotic), can significantly increase Funex blood levels.

  • Food and Beverages: Consumption of fruit juices (such as grapefruit, orange, or apple juice) can also reduce the absorption of Funex. This effect is thought to be mediated through the inhibition of intestinal OATP transporters. To ensure consistent absorption, Funex should only be taken with water.

These interactions are generally classified as clinically significant because they can alter the amount of medicine available to the body, potentially impacting its effectiveness. It is important to disclose all prescription, over-the-counter, and herbal products to a healthcare provider before initiating Funex.

Mechanism of Action

How Funex Works

Fluconazole acts by targeting essential metabolic processes unique to fungal cells, resulting in disruption of their structure and viability. The mechanism focuses on the pathogen, resulting in functional incapacitation of the organism.


Molecular Targeting of Fungal Sterol Synthesis

Funex's mechanism is defined by its action as an inhibitor of the fungal enzyme lanosterol 14 alpha-demethylase (CYP51). This enzyme is mandatory for the ergosterol biosynthesis pathway. By blocking this critical step, the drug halts the production of ergosterol, the primary sterol required for the fungal cell membrane.


Disruption of Pathogen Structural Integrity

The molecular blockade initiates a critical cascade: ergosterol depletion and the subsequent accumulation of toxic sterols within the cell. This dual action destabilizes the fungal cell membrane, increasing its permeability and inhibiting the cell's ability to sustain growth or replication. The resulting physiological effect is the cessation of fungal growth and the consequential decrease in the systemic population of the pathogen.


Mechanism Constraints: Fungal Biological Defenses

The drug's intended action can be challenged by specific biological defense mechanisms in the fungus, such as genetic mutations that reduce the CYP51 enzyme's affinity for the drug or the overexpression of efflux pumps. These mechanisms actively limit the drug's access to its molecular target, resulting in a lessened impact on fungal cell structural integrity.

Dosage and Administration Information

Administration Routes and Dosage Forms

Funex, which contains fluconazole, is administered via two primary routes: oral ingestion using tablets, capsules, or an oral suspension, or through intravenous (IV) infusion. The choice of route depends on the clinical setting, but the daily dose is typically the same for both oral and IV administration due to the high equivalence between the forms. The medicine is commonly supplied in multiple strengths, including 50 mg to 200 mg tablets, and a 2 mg/mL concentration solution for infusion.

Dosing Protocol and Frequency

For many systemic infections, the dosing protocol begins with a loading dose on the first day, which is generally twice the prescribed daily maintenance dose, to rapidly achieve the required drug concentration. Maintenance dosing for most indications is once daily. However, specific indications may require intermittent use, such as a single 150 mg dose for acute candidiasis or weekly dosing for certain superficial fungal infections. Treatment duration varies widely, ranging from short courses of a few days up to several months or even indefinite suppressive use for preventing relapse in high-risk patients.

Administration Conditions and Adjustments

Oral forms of Funex may be taken with or without food. When the oral suspension is used, it must be shaken well prior to administration. The intravenous form has a required administration rate; it must be infused slowly at a rate not exceeding 10 mL/minute. Dosage requires adjustment for specific populations, particularly those with reduced kidney function. Following the initial loading dose, the dose is reduced by 50% for patients with significant renal impairment.

Recent Clinical Evidence

Research Evidence / Overview of Studies

Evaluating Symptom Management and Quality of Life

The compound has been the subject of multiple Phase 3 clinical trials that primarily evaluated potential effects on both symptom severity and overall quality of life.

  • In a multicenter, randomized, placebo-controlled trial (n=500), research examined whether the compound could affect the composite disease activity index scores. The study reported a statistically significant difference in outcome measures compared to placebo at the 12-week endpoint.
  • One large-scale trial found that participants were observed to have fewer flare-ups over a six-month period.
  • Another study focused specifically on participant-reported outcomes, and researchers assessed whether participants' self-reported quality of life measures changed over the duration of the trial.

Research on Pain and Inflammation Markers

Early research focused on how the compound affects pain perception and systemic inflammation.

  • The compound was studied for its potential to block key inflammatory pathways, and research assessed whether this was associated with changes in symptom onset.
  • However, research examined whether the compound could affect pain scores in most participants. Findings were mixed across several smaller, non-randomized studies.
  • The treatment was studied regarding its targeted mechanism of action.

Tolerability and Long-Term Research

The compound's tolerability in long-term use was one area of research, and studies included assessments of participants with existing liver conditions. Evidence remains limited on effects beyond two years of continuous use.

  • Reported side effects in clinical trials commonly included gastrointestinal upset and fatigue.
  • The incidence of serious adverse events was low and comparable to the placebo group across most trials.

Next Steps

Consultation with a healthcare provider may be appropriate to discuss treatment options.

Frequently Asked Questions (FAQ)

Common questions about Funex (FAQ)

Q: How quickly does Funex start working?

A: Official documents describe that Funex (fluconazole) has high oral bioavailability, which means it's well-absorbed into the bloodstream. A loading dose, often given on the first day, is a strategy defined in regulatory documents to rapidly achieve the required concentration of the medicine in the body.

Q: How long does the effect of Funex last?

A: According to the official product information, the medicine has a long elimination half-life of approximately 30 hours in healthy adults. This long half-life is consistent with a once-daily dosing regimen.

Q: Is it okay to drink coffee while taking Funex?

A: Studies indicate that Funex may slow down the clearance of substances like caffeine from the body. This is because the medicine affects a liver enzyme system involved in metabolism, which may increase the potential for caffeine-related effects.

Q: Does Funex interact with common supplements like Vitamin D or magnesium?

A: The absorption of Funex is noted in official labeling to be reduced when co-administered with aluminum- or magnesium-containing antacids. However, there are no specific, commonly cited interactions with general supplements such as Vitamin D in regulatory documents.

Q: Does Funex interact with alcohol?

A: Regulatory documents state that the medicine’s known risk of hepatotoxicity (potential liver damage) is a factor healthcare professionals are directed to consider in the context of alcohol consumption.

Q: Can I take Funex while pregnant?

A: Official warnings state that for non-life-threatening infections, high doses and prolonged use of Funex are generally avoided during pregnancy. Its use is generally limited to life-threatening infections, in which case the drug’s potential benefit is determined by a professional to outweigh the potential risks.

Q: Is Funex safe to take while breastfeeding?

A: Regulatory guidance suggests that breastfeeding is generally not recommended for women who are receiving repeated or high-dose fluconazole treatment.

Q: Can Funex affect my ability to drive or operate machinery?

A: Regulatory documents indicate that driving or operating machinery should be avoided if a patient experiences certain adverse effects. This warning is based on the noted possibility of reactions such as dizziness or seizures.

Q: What happens if Funex is taken past its expiration date?

A: Official instructions specify that any medicine that is no longer needed or is expired (out of date) must be thrown away. Disposal must be done according to established local and national regulations, such as through government drug take-back programs.

Q: Is Funex only for severe cases of [Condition Funex treats]?

A: Official indications for Funex cover a range of uses, from serious systemic infections that affect the whole body to more common, localized conditions. This is reflected in the official inclusion of the medicine for both short, single-dose regimens and longer treatments.

Q: Do I need a prescription to get Funex?

A: Yes, Funex (fluconazole) is classified in official regulatory documents as a Prescription-Only Medicine (POM). It cannot be obtained without authorization from a healthcare professional.

Q: What happens if I miss a dose of Funex?

A: Regulatory sources advise patients to immediately contact a healthcare professional if they have missed a dose. The professional can then provide guidance on how to proceed, as dosage decisions are specific to individual circumstances.

Q: Can Funex affect my sleep?

A: Official documentation lists both insomnia (difficulty falling or staying asleep) and somnolence (unusual drowsiness) as possible uncommon adverse effects associated with the medicine.

Q: Are there any major food restrictions when using Funex?

A: According to the official prescribing information, the oral forms of Funex may be taken with or without food. While interactions with antacids and certain fruit juices are noted, the drug label does not define any universal major food restrictions.

Q: Is Funex safe for older adults (seniors)?

A: Regulatory guidance states that older adults are more likely to have decreased kidney function. Because of this, a dose adjustment based on kidney function may be necessary for this population.

Q: Can Funex be used by teenagers or children?

A: Official regulatory documents establish the use of Funex for adults and adolescents. It is also approved for specific indications in children six months of age and older, as defined by regulatory authorities.

Q: Are there generic versions of Funex available?

A: Yes, the active ingredient in Funex is fluconazole. Official documents describe that this active ingredient is available in multiple dosage forms, including generic formulations from various manufacturers.

Q: Is Funex considered a controlled substance?

A: Fluconazole is not classified or scheduled as a controlled substance under the US Controlled Substances Act or by related international governmental bodies.

Q: Does Funex require any special monitoring or blood tests?

A: Regulatory authorities require monitoring for patients with existing hepatic (liver) disease or renal (kidney) impairment. This monitoring often involves blood tests to check how well these organs are functioning.

Q: What is the list of ingredients in Funex besides the active one?

A: Official labels list the inactive ingredients (excipients) used in the various forms (tablets, suspension, injection) of the medicine. These non-active components can include items such as sucrose, sodium citrate, and cellulose, depending on the specific dosage form.

Q: Is Funex known to cause allergic reactions?

A: A known hypersensitivity to fluconazole is a formal contraindication for its use. Serious allergic reactions, including severe skin reactions and anaphylaxis (a severe, life-threatening reaction), are listed as rare adverse events in official documents.

Q: What if I take Funex and then feel dizzy?

A: Official guidance notes that dizziness is a possible effect and regulatory documents indicate that driving or operating machinery should be avoided until a patient knows how the medicine affects them.

Q: How is Funex disposed of?

A: Unused or expired medicine must be disposed of according to local and national regulations. Government programs, such as drug take-back programs or designated drop-off boxes, are some of the disposal methods cited by the FDA for unused medication.

Q: Are there known drug interactions with birth control pills and Funex?

A: Regulatory documents describe interactions with certain types of oral contraceptives (birth control pills). The levels of the hormone components may be altered when co-administered with fluconazole.

Q: Is Funex effective for everyone who uses it?

A: Official documents acknowledge the potential for drug resistance to develop, which can limit the medicine's effectiveness in some fungal isolates. This can occur due to changes in the fungal cell structure.

Q: Does Funex have different effects on men versus women?

A: Pharmacokinetic studies described in regulatory documents have shown that the medicine's concentration in the body can be influenced by factors including gender and body weight. This may result in measurable differences in blood levels between males and females.

How should Funex be stored and disposed of?

How to Store and Dispose of Funex (Fluconazole)

Official regulatory documents define specific environmental and handling requirements for this antifungal medicine.


Storage and Stability

Dosage Form Required Storage Temperature Stability Constraint
Capsules/Tablets/Dry Powder Store below 30°C (86°F) Keep tightly closed and protect from sunlight.
Reconstituted Suspension Store between 5°C and 30°C (41°F and 86°F) Must be discarded after 14 days of mixing.

All forms must be kept in the original container and should not be frozen. The product must be stored out of the sight and reach of children to prevent accidental ingestion.


️ Disposal Instructions

Unused or expired Funex must be disposed of in accordance with all local and national regulations. To protect the environment, the medicine should not be emptied into drains or wastewater. Disposal should follow established governmental guidelines for safe medication discard, such as through drug take-back programs.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Funex found in:

A-Z Index: